NEWSMAX
Active· since Aug 7, 2026
- 40
- days running
- 1
- relaunches
Ad copy
An experimental weight-loss drug produced striking reductions in liver fat during a preliminary study. Researchers say Retatrutide could eventually offer a new approach to obesity-related fatty liver disease—but it is not yet FDA-approved, and further research is needed. See what the study found.
Experimental Drug Shows Promise for Liver Fat
Researchers report preliminary findings involving Retatrutide. - Experimental Weight-Loss Drug Delivering Results On Par With Surgery
LEARN MORE🪄Crush AI
Like this ad? Make it yours.
Crush rebuilds this exact creative around your product — your brand, your colors, your offer — in about a minute.
